9 November 2023 Anti JAKS Dermatology Plaque psoriasis Psoriatic Athritis

Anti-JAKs safe in skin conditions

2 November 2023 Anti JAKS Rheumatoid Arthritis Vaccines

Shingrix works in at-risk JAKi patients, so why can’t they get it?

8 June 2023 Anti JAKS Biologics EULAR Rheumatoid Arthritis

JAKis don’t beat TNFis in high-risk patients

5 June 2023 Anti JAKS EULAR Rheumatoid Arthritis Sjogren Syndrom

Dual JAK1/TYK2 inhibitor outperforms tofacitinib

5 June 2023 Anti JAKS EULAR Rheumatoid Arthritis

CV and cancer risks with JAKi: EULAR perspectives

4 May 2023 Anti JAKS TGA

Black box warning but no smoking gun for class effect yet

23 March 2023 Anti JAKS Research

ORAL Surveillance risk groups narrow again

9 March 2023 Anti JAKS Psoriatic Athritis Rheumatoid Arthritis

More real-world reassurance for JAKi and cancer

2 March 2023 Anti JAKS Lupus

‘Back to the drawing board’ for JAKi in lupus

Sponsored {{ ::category.name }}

Brought to you by {{ ::post.advertiser.name }}